|
1
|
Loei H, Tan HT, Lim TK, Lim KH, So JB,
Yeoh KG and Chung MC: Mining the gastric cancer secretome:
identification of GRN as a potential diagnostic marker for early
gastric cancer. J Proteome Res. 11:1759–1172. 2012. View Article : Google Scholar
|
|
2
|
Yu X, Luo L, Wu Y, Yu X, Liu Y, Yu X, Zhao
X, Zhang X, Cui L, Ye G, et al: Gastric juice miR-129 as a
potential biomarker for screening gastric cancer. Med Oncol.
30:3652013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tan YK and Fielding JW: Early diagnosis of
early gastric cancer. Eur J Gastroenterol Hepatol. 18:821–829.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li C, Li JF, Cai Q, Qiu QQ, Yan M, Liu BY
and Zhu ZG: MiRNA-199a-3p: A potential circulating diagnostic
biomarker for early gastric cancer. J Surg Oncol. 108:89–92. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carpelan-Holmström M, Louhimo J, Stenman
UH, Alfthan H and Haglund C: CEA, CA 19-9 and CA 72-4 improve the
diagnostic accuracy in gastrointestinal cancers. Anticancer Res.
22:2311–2316. 2002.PubMed/NCBI
|
|
6
|
Lukaszewicz-Zając M, Mroczko B, Gryko M,
Kędra B and Szmitkowski M: Comparison between clinical significance
of serum proinflammatory proteins (IL-6 and CRP) and classic tumor
markers (CEA and CA 19-9) in gastric cancer. Clin Exp Med.
11:89–96. 2011. View Article : Google Scholar
|
|
7
|
Kikuchi R, Tsuda H, Kozaki K, Kanai Y,
Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J and Imoto I:
Frequent inactivation of a putative tumor suppressor,
angiopoietin-like protein 2, in ovarian cancer. Cancer Res.
68:5067–5075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oike Y, Yasunaga K and Suda T:
Angiopoietin-related/angiopoietin-like proteins regulate
angiogenesis. Int J Hematol. 80:21–28. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sfiligoi C, de Luca A, Cascone I, Sorbello
V, Fuso L, Ponzone R, Biglia N, Audero E, Arisio R, Bussolino F, et
al: Angiopoietin-2 expression in breast cancer correlates with
lymph node invasion and short survival. Int J Cancer. 103:466–474.
2003. View Article : Google Scholar
|
|
10
|
Endo M, Nakano M, Kadomatsu T, Fukuhara S,
Kuroda H, Mikami S, Hato T, Aoi J, Horiguchi H, Miyata K, et al:
Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical
driver of metastasis. Cancer Res. 72:1784–1794. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jass JR and Sobin LH: Histological Typing
of Intestinal Tumours. 2nd edition. Springer-Verlag;
Berlin-Heidelberg-New York: 1989, View Article : Google Scholar
|
|
12
|
Okada T, Tsukano H, Endo M, Tabata M,
Miyata K, Kadomatsu T, Miyashita K, Semba K, Nakamura E, Tsukano M,
et al: Synoviocyte-derived angiopoietin-like protein 2 contributes
to synovial chronic inflammation in rheumatoid arthritis. Am J
Pathol. 176:2309–2319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Presta LG, Chen H, O’Connor SJ, Chisholm
V, Meng YG, Krummen L, Winkler M and Ferrara N: Humanization of an
anti-vascular endothelial growth factor monoclonal antibody for the
therapy of solid tumors and other disorders. Cancer Res.
57:4593–4599. 1997.PubMed/NCBI
|
|
14
|
Wang Q, Diao X, Sun J and Chen Z: Stromal
cell-derived factor-1 and vascular endothelial growth factor as
biomarkers for lymph node metastasis and poor cancer-specific
survival in prostate cancer patients after radical prostatectomy.
Urol Oncol. 31:312–317. 2013. View Article : Google Scholar
|
|
15
|
Tabata M, Kadomatsu T, Fukuhara S, Miyata
K, Ito Y, Endo M, Urano T, Zhu HJ, Tsukano H, Tazume H, et al:
Angiopoietin-like protein 2 promotes chronic adipose tissue
inflammation and obesity-related systemic insulin resistance. Cell
Metab. 10:178–188. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Doi Y, Ninomiya T, Hirakawa Y, Takahashi
O, Mukai N, Hata J, Iwase M, Kitazono T, Oike Y and Kiyohara Y:
Angiopoietin-like protein 2 and risk of type 2 diabetes in a
general Japanese population: the Hisayama study. Diabetes Care.
36:98–100. 2013. View Article : Google Scholar
|
